Almstead Neil Gregory bought PTCT
January 2, 2026 · Form 4 insider transaction
Almstead Neil Gregory bought 17,500 shares of PTC Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,500
Price
$0.00
Total value
N/A
InsiderAlmstead Neil Gregory
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after118,382
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.; Includes 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025.